rubidium has been researched along with technetium tc 99m exametazime in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babich, JW; Coghlan, G; Hammersley, PA; McCready, VR | 1 |
| Boswell, CA; Bumbaca, D; Fielder, PJ; Johnstone, B; Khawli, LA; Mundo, EE; Prabhu, S; Schweiger, MG; Ulufatu, S | 1 |
2 other study(ies) available for rubidium and technetium tc 99m exametazime
| Article | Year |
|---|---|
99mTc-HMPAO as a tumour blood flow agent.
Topics: Animals; Chlorides; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Organometallic Compounds; Oximes; Radioisotopes; Radionuclide Imaging; Rubidium; Technetium Tc 99m Exametazime; Tissue Distribution | 1987 |
Vascular physiology and protein disposition in a preclinical model of neurodegeneration.
Topics: Amyotrophic Lateral Sclerosis; Animals; Blood Volume; Blood-Brain Barrier; Cerebrovascular Circulation; Chlorides; Disease Models, Animal; Drug Delivery Systems; Female; Humans; Immunoglobulin G; Mice; Mice, Mutant Strains; Mice, Transgenic; Nerve Degeneration; Protein Transport; Radionuclide Imaging; Radiopharmaceuticals; Rubidium; Rubidium Radioisotopes; Superoxide Dismutase; Technetium Tc 99m Exametazime; Tissue Distribution | 2013 |